Bio-Techne Corporation (BVMF:T1CH34)

Market Cap	50.66B
Revenue (ttm)	6.48B
Net Income (ttm)	415.42M
Shares Out	n/a
EPS (ttm)	2.59
PE Ratio	121.96
Forward PE	30.29
Dividend	0.04 (0.40%)
Ex-Dividend Date	Aug 15, 2025

Volume	23
Average Volume	51
Open	10.74
Previous Close	n/a
Day's Range	10.74 - 10.74
52-Week Range	8.92 - 16.38
Beta	1.47
RSI	52.41
Earnings Date	Nov 5, 2025

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue cultur...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Employees: 3,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: T1CH34

Financial Performance

In 2025, Bio-Techne's revenue was $1.22 billion, an increase of 5.23% compared to the previous year's $1.16 billion. Earnings were $73.36 million, a decrease of -56.35%.

Financial numbers in USD